AD
2024-08-01 17:41:00 +0300

Rafa Laboratories to acquire a significant stake in ExCEEd Orphan and expand its international capabilities in...

Logo Benzinga
Benzinga
By Pr Newswire

JERUSALEM and PRAGUE, Czech Republic, Aug. 1, 2022 /PRNewswire/ --Rafa Laboratories LTD. (Rafa) and ExCEEd Orphan s.r.o (ExCEEd) announced today a strategic collaboration for medicines addressing rare diseases in Central and Eastern Europe (CEE) and Israel. Under the agreement, and as part of its strategy to become an international player, Rafa will invest in ExCEEd an undisclosed amount that shall enable it to strengthen its market access capabilities in the region and move closer to fulfilling its vision to become a leading player in this important mission of pioneering access to patients with rare diseases. Furthermore, the parties shall collaborate on bringing new medicines for rare diseases to both the CEE and Israel.

AD
AD

The worldwide orphan drug market is growing over twice as fast as the non-orphan market, with expected 2021-2026 CAGR of 12%. By 2026, global orphan drug sales are expected to reach $273b and account for 20% of all prescription drug sales1. With a CEE population of approximately 120 million2, a pharmaceutical market value of $24.7b in 20203and growing economies, the demand in CEE for solutions to rare diseases is increasing, while the number of medicines currently available in this region is considerably lower than in the rest of Europe.

A strong vote of confidence in ExCEEd is demonstrated by agreements signed within the last 15 months with leading innovative pharma companies, among them Amryt, Mirum and SERB. These collaborative agreements have laid a sturdy foundation for future alliances in this arena.

Continue read on benzinga.com

AD
Logo Nasdaq
MarketsBy Zacks2024-07-14 18:34:00 +0300
Amryt Pharma plc AMYT announced that the FDA has granted Orphan Drug designation to its marketed product, Mycapssa (oral octreotide), for the treatment of...

Logo Benzinga
MarketsBy Ragothaman Srinivasan2024-07-14 15:12:50 +0300
The US Food and Drug Administration (FDA) has granted Orphan Drug Designation to Amryts AMYT lead drug Mycapssa for the treatment of carcinoid syndrome....

Logo Benzinga
MarketsBy Ragothaman Srinivasan2024-07-05 19:05:55 +0300
Chinook Therapeutics, Inc. KDNY announced that the European Commission has granted orphan drug designation for BION-1301 for the treatment of primary IgA...

Logo Benzinga
Business / FinanceBy Globe Newswire2024-07-25 13:30:00 +0300
BEDMINSTER, N.J., July 25, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE AMER: MTNB), a clinical-stage biopharmaceutical companyfocused on improving the...

Logo Benzinga
MarketsBy Ragothaman Srinivasan2024-07-13 15:06:31 +0300
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for AVROBIOs AVRO lead drug AVR-RD-05 for the treatment of...

Logo Benzinga
Business / FinanceBy Pr Newswire2024-07-08 09:59:00 +0300
Agreement augments Sobi's strategic presence in haematology with new orphan medicine STOCKHOLM, July 8, 2024 /PRNewswire/ --Sobi today announced an exclusive...

Logo Benzinga
Business / FinanceBy Globe Newswire2024-07-08 15:17:00 +0300
BRIDGEWATER, N.J., July 08, 2024 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. HILS (Hillstream or the Company), a biotechnology company developing novel...

Logo Benzinga
Business / FinanceBy Business Wire2024-07-11 15:05:00 +0300
Cyclo Therapeutics, Inc. CYTH (Cyclo Therapeutics or the Company), a clinical stage biotechnology company dedicated to developing life-changing medicines...

Logo Nasdaq
MarketsBy Rtt News2024-07-06 15:00:22 +0300
(RTTNews) - The United States Food and Drug Administration has awarded Rare Pediatric Disease Designation to Kazia Therapeutics Ltd's (KZIA, KZA.AX)...

Logo Nasdaq
MarketsBy Zacks2024-07-15 16:47:00 +0300
Ultragenyx Pharmaceutical Inc. RARE announced that it has sold 30% of the royalty interests it receives from partner Kyowa Kirin on future sales of its rare...

Logo Benzinga
Business / FinanceBy Pr Newswire2024-07-05 10:00:00 +0300
CAMBRIDGE, United Kingdom and TOKYO, July 5, 2024 /PRNewswire/ -- Mogrify Limited (CEO: Darrin M. Disley, Ph.D., Mogrify), a biopharmaceutical company...

Logo Benzinga
Business / FinanceBy Pr Newswire2024-07-18 03:00:00 +0300
Kinpeygo (developed under the name NEFECON) is the first and only EMA- approved treatment for IgAN Everest Medicines has exclusive rights to develop and...

The Spinal Muscular Atrophy Medicine Market expected to grow considerably in the forecast period 2022- 2026. The Research report (123 pages) sheds light on...

Logo GlobeNewswire
Business / FinancePress Release2024-07-18 18:57:00 +0300
Tel Aviv, July 18, 2024 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL) is pleased to announce that the Companys subsidiary, Cannovation Center Israel...

Logo Benzinga
Business / FinanceBy Pr Newswire2024-07-05 09:15:00 +0300
EDINBURGH, Scotland, July 5, 2024 /PRNewswire/ --Scotland is on its way to becoming home to the UK's largest connected laboratory medicine network, following...

Logo Benzinga
Business / FinanceBy Globe Newswire2024-08-01 13:23:33 +0300
Dublin, Aug. 01, 2022 (GLOBE NEWSWIRE) -- The Implantable Drug Delivery Devices Global Market Report 2022 report has been added to ResearchAndMarkets.com's...

Logo Benzinga
Business / FinanceBy Globe Newswire2024-07-28 12:48:35 +0300
Dublin, July 28, 2024 (GLOBE NEWSWIRE) -- The Global Peptide Therapeutics Market (by Type, Synthesis Technology, Manufacturing Type, Application &...

Logo Benzinga
Business / FinanceBy Business Wire2024-07-29 15:45:00 +0300
- - Enrollment of PNH Patients Expected to Begin this Summer -- Omeros Corporation today announced that OMS906 has received orphan drug designation from the...

Logo Benzinga
Business / FinanceBy Business Wire2024-07-22 13:05:00 +0300
Positive CHMP opinion is based on a comprehensive submission including data from the pivotal AURORA 1 efficacy study and the AURORA 2 continuation study,...

Final report will add the analysis of the impact of COVID-19 on this industry. Parkinson Disease Drug Market – Insights: The Parkinson Disease Drug Market...